Clinical Trial Update: Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating changes in apoptosis regulators after stopping 5-aminosalicylic acid treatment in inactive ulcerative colitis has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• 5-aminosalicylic acid (mesalamine) (mesalamine)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 4 | Status: TERMINATED